“I was so tickled when we hired Mark; he is a blessing for Rx-360 and he is a full-time leader. It’s no longer myself or Brian Johnson or Lynn Byers running Rx-360 as a side job – Mark is only dedicated to Rx-360. He has a wealth of experience from the FDA and the pharma industry, and brings the unique skillset of a lawyer. He’s done some fantastic work with regulators, the World Health Organization, charities, and making in-roads into China. And I have high expectations that he will continue do great things. Mark really believes in the driving mission of Rx-360 – and you have to believe for others to follow you.” – Martin van Trieste
- Developing voluntary standards for the quality and authenticity of supplies and suppliers.
- Developing and implementing audit standards and auditor training and certification regarding the quality and authenticity of supplies and suppliers.
- Joint development of technologies to enhance the quality and authenticity of supplies.
- Developing and implementing a method for exchanging, between members, public information regarding the quality and authenticity of supplies and suppliers and non-public information regarding the quality and authenticity of supplies and suppliers that could adversely impact patient health or welfare.
- Adoption of a seal for use by members that meet the consortium’s standards.
Rx-360 was initially set up with a large law firm, Drinker Biddle and Reath LLP, serving as the administrative function for the organization. As Rx-360 started grow, it became clear that it needed to migrate to a more traditional business model, which led to the search for a CEO. Ultimately, Mark Paxton was chosen for the role in October 2015.
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
